The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination—Review of Current Perspectives
Open accessAbstract
Viral infections contribute as a cause of 15–20% of all human cancers. Infection by oncogenic viruses can promote different stages of carcinogenesis. Among many types of HPV, around 15 are linked to cancer. In spite of effective screening methods, cervical cancer continues to be a major public health problem. There are wide differences in cervical cancer incidence and mortality by geographic region. In addition, the age-specific HPV prevalence varies widely across different populations and showed two peaks of HPV positivity in younger and older women. There have been many studies worldwide on the epidemiology of HPV infection and oncogenic properties due to different HPV genotypes. However, there are still many countries where the population-based prevalence has not yet been identified. Moreover, cervical cancer screening strategies are different between countries. Organized cervical screening programs are potentially more effective than opportunistic screening programs. Nevertheless, screening programs have consistently been associated with a reduction in cervical cancer incidence and mortality. Developed countries have achieved such reduced incidence and mortality from cervical cancer over the past 40 years. This is largely due to the implementation of organized cytological screening and vaccination programs. HPV vaccines are very effective at preventing infection and diseases related to the vaccine-specific genotypes in women with no evidence of past or current HPV infection. In spite of the successful implementation of the HPV vaccination program in many countries all over the world, problems related to HPV prevention and treatment of the related diseases will continue to persist in developing and underdeveloped countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766 · cited 2×
“+e majority of cervical cancer cases are squamous cell carcinoma [41].”
BackgroundEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Cohen, P. A., Jhingran, A., Oaknin, A., & Denny, L. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32470-x · Cited by 2,412
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810
de Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N., & Bosch, F. X. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70158-5 · Cited by 1,669 · cited 16×
“At the same time, cervical cancer prevalence remains at a high level in developing countries of Central and South-East Asia, Africa, and Eastern Europe, where cervical cancer screening programs are not properly implemented due to a variety of reasons (socioeconomic, geographic, etc.).”
BackgroundInfluentialClassification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
Bernard, H.-U., Burk, R. D., Chen, Z., van Doorslaer, K., Hausen, H. Z., & de Villiers, E.-M. (2010) · Virology · doi:10.1016/j.virol.2010.02.002 · Cited by 1,669
Bruni, L., Diaz, M., Castellsagué, X., Ferrer, E., Bosch, F. X., & de Sanjosé, S. (2010) · The Journal of Infectious Diseases · doi:10.1086/657321 · Cited by 1,641
McCredie, M. R., Sharples, K. J., Paul, C., Baranyai, J., Medley, G., Jones, R. W., & Skegg, D. C. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70103-7 · Cited by 1,123
Clifford, G., Gallus, S., Herrero, R., Muñoz, N., Snijders, P., Vaccarella, S., Anh, P., Ferreccio, C., Hieu, N., Matos, E., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67069-9 · Cited by 1,093
Screening for cervical cancer: U.S. preventive services Task force recommendation statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-12-201206190-00424 · Cited by 1,049
Carcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Arbyn, M., Anttila, A., Jordan, J., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 760
Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., Brawley, O. W., & Wender, R. C. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21392 · Cited by 719
Drolet, M., Bénard, É., Boily, M.-C., Ali, H., Baandrup, L., Bauer, H., Beddows, S., Brisson, J., Brotherton, J. M. L., Cummings, T., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)71073-4 · Cited by 642
Cancer Screening Test Use — United States, 2015
White, A., Thompson, T. D., White, M. C., Sabatino, S. A., de Moor, J., Doria-Rose, P. V., Geiger, A. M., & Richardson, L. C. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6608a1 · Cited by 599
Kjaer, S. K., Frederiksen, K., Munk, C., & Iftner, T. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq356 · Cited by 579
Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent Infections
Rodriguez, A. C., Schiffman, M., Herrero, R., Wacholder, S., Hildesheim, A., Castle, P. E., Solomon, D., Burk, R., & On behalf of the Proyecto Epidemiologico Guanacaste Group (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn044 · Cited by 549
Garland, S. M., Kjaer, S. K., Muñoz, N., Block, S. L., Brown, D. R., DiNubile, M. J., Lindsay, B. R., Kuter, B. J., Perez, G., Dominiak-Felden, G., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw354 · Cited by 497
Human papillomavirus genome variants
Burk, R. D., Harari, A., & Chen, Z. (2013) · Virology · doi:10.1016/j.virol.2013.07.018 · Cited by 484
Pathology and epidemiology of HPV infection in females
Stanley, M. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.01.024 · Cited by 470
The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets
Hoppe-Seyler, K., Bossler, F., Braun, J. A., Herrmann, A. L., & Hoppe-Seyler, F. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2017.07.007 · Cited by 457
Screening for cervical cancer: a systematic review and meta-analysis
Peirson, L., Fitzpatrick-Lewis, D., Ciliska, D., & Warren, R. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-35 · Cited by 431
Viruses associated with human cancer
McLaughlin-Drubin, M. E., & Munger, K. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.12.005 · Cited by 406
Nakagawa, S., & Huibregtse, J. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.8244-8253.2000 · Cited by 382
Lee, S. S., Weiss, R. S., & Javier, R. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6670 · Cited by 356
Cervical Cancer Trends in the United States: A 35-Year Population-Based Analysis
Adegoke, O., Kulasingam, S., & Virnig, B. (2012) · Journal of Women's Health · doi:10.1089/jwh.2011.3385 · Cited by 343
Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
Gertig, D. M., Brotherton, J. M., Budd, A. C., Drennan, K., Chappell, G., & Saville, A. M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-227 · Cited by 277
Moscicki, A.-B., Ma, Y., Wibbelsman, C., Darragh, T. M., Powers, A., Farhat, S., & Shiboski, S. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181fe777f · Cited by 274
Glaunsinger, B. A., Lee, S. S., Thomas, M., Banks, L., & Javier, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203906 · Cited by 264
Viral oncoproteins target the DNA methyltransferases
Burgers, W. A., Blanchon, L., Pradhan, S., Launoit, Y. D., Kouzarides, T., & Fuks, F. (2007) · Oncogene · doi:10.1038/sj.onc.1209950 · Cited by 242
Palmer, T., Wallace, L., Pollock, K. G., Cuschieri, K., Robertson, C., Kavanagh, K., & Cruickshank, M. (2019) · BMJ · doi:10.1136/bmj.l1161 · Cited by 237
Explanations for the high potency of HPV prophylactic vaccines
Schiller, J., & Lowy, D. (2018) · Vaccine · doi:10.1016/j.vaccine.2017.12.079 · Cited by 225
Reid, R., Stanhope, C. R., Herschman, B. R., Booth, E., Phibbs, G. D., & Smith, J. P. (1982) · Cancer · Cited by 214
HPV-FASTER: broadening the scope for prevention of HPV-related cancer
Bosch, F. X., Robles, C., Díaz, M., Arbyn, M., Baussano, I., Clavel, C., Ronco, G., Dillner, J., Lehtinen, M., Petry, K.-U., et al. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.146 · Cited by 206
White, E. A., Kramer, R. E., Tan, M. J. A., Hayes, S. D., Harper, J. W., & Howley, P. M. (2012) · Journal of Virology · doi:10.1128/jvi.02172-12 · Cited by 198
Insinga, R. P., Dasbach, E. J., & Elbasha, E. H. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-119 · Cited by 170
Pathogenesis of human papillomavirus‐associated mucosal disease
Groves, I. J., & Coleman, N. (2015) · The Journal of Pathology · doi:10.1002/path.4496 · Cited by 164
Rositch, A. F., Burke, A. E., Viscidi, R. P., Silver, M. I., Chang, K., & Gravitt, P. E. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2635 · Cited by 162
Zhang, B., Chen, W., & Roman, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510012103 · Cited by 156
Asiaf, A., Ahmad, S. T., Mohammad, S. O., & Zargar, M. A. (2013) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328364f273 · Cited by 149
Skinner, S. R., Wheeler, C. M., Romanowski, B., Castellsagué, X., Lazcano-Ponce, E. C., Rosario‐Raymundo, M. R. D., Vallejos, C. S., Minkina, G., da Silva, D. P., McNeil, S., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29971 · Cited by 142
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Knowledge, Attitudes, Practices, and Perceived Risk of Cervical Cancer Among Kenyan Women
Sudenga, S. L., Rositch, A. F., Otieno, W. A., & Smith, J. S. (2013) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31828e425c · Cited by 139
Mirabello, L. J., Clarke, M. A., Nelson, C. W., Dean, M. C., Wentzensen, N., Yeager, M., Cullen, M., Boland, J. F., Workshop, N. H., SCHIFFMAN, M. H., et al. (2018) · Viruses · doi:10.3390/v10020080 · Cited by 139
Molecular Mechanisms of Human Papillomavirus-Induced Carcinogenesis
Lehoux, M., D’Abramo, C. M., & Archambault, J. (2009) · Public Health Genomics · doi:10.1159/000214918 · Cited by 137
Mechanisms by which HPV Induces a Replication Competent Environment in Differentiating Keratinocytes
Moody, C. A. (2017) · Viruses · doi:10.3390/v9090261 · Cited by 132
Gravitt, P. E., Rositch, A. F., Silver, M. I., Marks, M. A., Chang, K., Burke, A. E., & Viscidi, R. P. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis660 · Cited by 130
Pande, S., Jain, N. D., Prusty, B. K., Bhambhani, S., Gupta, S. K., Sharma, R., Batra, S., & Das, B. C. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02202-07 · Cited by 125
Canfell, K., Sitas, F., & Beral, V. (2006) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00661.x · Cited by 117
Bray, F., Lortet‐Tieulent, J., Znaor, A., Brotons, M., Poljak, M., & Arbyn, M. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.02.071 · Cited by 112
Sankaranarayanan, R., Anorlu, R. I., Sangwa‐Lugoma, G., & Denny, L. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.06.066 · Cited by 110
Jung, H. M., Phillips, B. L., & Chan, E. K. L. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-80 · Cited by 105
Wheeler, C. M. (2008) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2008.09.006 · Cited by 102
Cervical cancer screening programs and guidelines in low‐ and middle‐income countries
Olson, B., Gribble, B., Dias, J., Curryer, C., Vo, K., Kowal, P. R., & Byles, J. (2016) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2016.03.011 · Cited by 97
Glick, S. B., Clarke, A. R., Blanchard, A., & Whitaker, A. K. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-012-2052-2 · Cited by 94
Cattani, P., Zannoni, G. F., Ricci, C., D’Onghia, S., Trivellizzi, I. N., Franco, A. D., Vellone, V. G., Durante, M., Fadda, G., Scambia, G., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01275-09 · Cited by 81
Neveu, G., Cassonnet, P., Vidalain, P., Rolloy, C., Mendoza, J., Jones, L. M., Tangy, F., Muller, M., Demeret, C., Tafforeau, L., et al. (2012) · Methods · doi:10.1016/j.ymeth.2012.07.029 · Cited by 79
Ивановна, Р. С., Петровна, Ш. И., Mikheeva, I. V., Minkina, G., Podzolkova, N. M., Shipulina, O. Y., С.Н, С., Kosenko, I. A., Brotons, M., Buttmann‐Schweiger, N., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.06.043 · Cited by 75
Cervical Cancer Screening in Resource-Constrained Countries: Current Status and Future Directions
Gupta, R., Gupta, S. K., Mehrotra, R., & Sodhani, P. (2017) · PubMed Central · doi:10.22034/apjcp.2017.18.6.1461 · Cited by 71
Kangmennaang, J., Onyango, E. O., Luginaah, I., & Elliott, S. J. (2017) · Social Science & Medicine · doi:10.1016/j.socscimed.2017.12.013 · Cited by 71
Cervical Cancer Screening Among Women Aged 18-30 Years—United States, 2000-2010
(2013) · JAMA · doi:10.1001/jama.2013.107 · Cited by 68
Telomerase Induction in HPV Infection and Oncogenesis
Katzenellenbogen, R. A. (2017) · Viruses · doi:10.3390/v9070180 · Cited by 66
Bansal, D., Elmi, A. A., Skariah, S., Haddad, P., Abu-Raddad, L. J., Hamadi, A. H. A., Mohamed-Nady, N., Afifi, N. M., Ghedira, R., Hassen, E., et al. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0300-4 · Cited by 49
Altobelli, E., Rapacchietta, L., Profeta, V. F., & Fagnano, R. (2019) · Cancer Medicine · doi:10.1002/cam4.2048 · Cited by 48
Wong, C. A., Saraiya, M., Hariri, S., Eckert, L. O., Howlett, R. I., Markowitz, L. E., Brotherton, J. M. L., Sinka, K., Martínez-Montañez, O. G., Kjær, S. K., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.018 · Cited by 43
Campos, N. G., Tsu, V. D., Jerónimo, J., Mvundura, M., & Kim, J. J. (2017) · Cancer Medicine · doi:10.1002/cam4.1123 · Cited by 43
Zucchetto, A., Ronco, G., Rossi, P. G., Zappa, M., Ferretti, S., Franzo, A., Falcini, F., Visioli, C. B., Zanetti, R., Biavati, P., et al. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.05.018 · Cited by 40
Impact of HPV vaccination: Achievements and future challenges
Brotherton, J. M. L. (2019) · Papillomavirus Research · doi:10.1016/j.pvr.2019.04.004 · Cited by 38
Tanaka, H., Shirasawa, H., Shimizu, D., Sato, N., 大山, 則., Takahashi, O., & Terada, Y. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13419 · Cited by 35
Distance Traveled for Treatment of Cervical Cancer
Gunderson, C. C., Nugent, E. K., McMeekin, D. S., & Moore, K. N. (2013) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e3182989464 · Cited by 34
Bucchi, L., Baldacchini, F., Mancini, S., Ravaioli, A., Giuliani, O., Vattiato, R., Falcini, F., Rossi, P. G., Campari, C., Canuti, D., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31806 · Cited by 30
The prevalence of human papillomavirus infection in Mombasa, Kenya
Vuyst, H. D., Parisi, M. R., Karani, A., Mandaliya, K. N., Muchiri, L. W., Vaccarella, S., Temmerman, M., Franceschi, S., & Lillo, F. B. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9645-z · Cited by 29
Methylation status of the long control region of HPV 16 in clinical cervical specimens
Hong, D., Ye, F., Lü, W., Hu, Y. C., Wan, X., Chen, Y., & Xie, X. (2008) · Molecular Medicine Reports · doi:10.3892/mmr.1.4.555 · Cited by 29
Tornesello, M. L., CASSESE, R., Rosa, N. D., Buonaguro, L., Masucci, A., Vallefuoco, G., Palmieri, S., Schiavone, V., Piccoli, R., & Buonaguro, L. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02784.x · Cited by 29
Niyazmetova, L., Aimagambetova, G. N., Stambekova, N., Abugalieva, Z., Seksembayeva, K., Ali, S., & Azizan, A. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.11.410 · Cited by 29
Self-citationJing, Y., Wang, T., Chen, Z., Ding, X., Xu, J., Mu, X., Cao, M., & Chen, H. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8743 · Cited by 29
White, M. C., & Wong, F. L. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0541-4 · Cited by 19
Grabowski, M. K., Gravitt, P. E., Gray, R. H., Serwadda, D. M., Redd, A. D., Kigozi, G., Kong, X., Nalugoda, F. K., Wawer, M. J., Quinn, T. C., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw631 · Cited by 11
Cited by
Neoantigens: promising targets for cancer therapy
Xie, N., Shen, G., Gao, W., Huang, Z., Huang, C., & Fu, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01270-x · Cited by 1,020
Metadata
- Authors
- Chan, C. K., Aimagambetova, G., Ukybassova, T., Kongrtay, K., & Azizan, A.
- Venue
- Journal of Oncology
- Publisher
- Wiley
- Published
- 2019-10-10
- Volume
- 2019
- Pages
- 1-11
- ISSN
- 1687-8450 (ISSN-L)
- 1687-8469
- OpenAlex
- W2980284610
- Cited by
- 494
- References
- 79
- FWCI
- 36.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.